The PSI has collected data on counterfeiting, illegal diversion, and theft incidents for 23 consecutive years. In CY 2025, PSI documented 7,152 pharmaceutical crime incidents—an 11% year-over-year increase and the highest annual total recorded since PSI began tracking pharmaceutical crime.

 

These record incident levels underscore a rapidly evolving threat environment in which criminal networks are increasingly exploiting demand, access constraints, and supply chain vulnerabilities. Addressing this escalating risk will require sustained collaboration among PSI members and continued engagement with law enforcement, customs authorities, and drug regulators through intelligence sharing, enforcement support, and risk-mitigation efforts.